Filing Flows › Intelligent Bio Solutions (INBS) › Q4 FY26 › vs Q3 FY26
Intelligent Bio Solutions (INBS) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Intelligent Bio Solutions's revenue rose $85K (+8%) from $1.1M in Q3 FY26 to $1.1M in Q4 FY26. The biggest changes: Sales of Goods - Readers +$90K (+65%); Sales of Goods - Cartidges −$79K (-11%); Other sales - accessories +$74K (+34%).
Intelligent Bio Solutions, Q4 FY26: revenue $1.1M (+36% year over year), operating margin -346.4%, net loss $3.9M, operating cash flow −$3.2M. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Sales of Goods - Cartidges | $625K | $704K | −$79K | -11% |
| Other sales - accessories | $291K | $218K | $74K | +34% |
| Sales of Goods - Readers | $229K | $139K | $90K | +65% |
| Revenue | $1.1M | $1.1M | $85K | +8% |
| Other income, net | $51K | $77K | −$26K | -34% |
| Net loss | $3.9M | $2.9M | $1.0M | +37% |
| Costs & expenses | $5.1M | $4.0M | $1.1M | +28% |
| Operating costs | $5.1M | $4.0M | $1.1M | +28% |
| Cost of revenue | $609K | $525K | $84K | +16% |
| SG&A | $3.0M | $2.5M | $531K | +22% |
| Other operating costs | $1.5M | $1.0M | $492K | +48% |
| Operating cash sources | $3.9M | $2.9M | $1.0M | +37% |
| Depreciation & amortization | $288K | $290K | −$2K | -0.8% |
| Share-based compensation | $97K | $24K | $73K | +303% |
| Working capital & other | $350K | −$1.8M | $2.1M | — |
| Cash used in operations | $3.2M | $4.3M | −$1.1M | -27% |
| Net loss absorbed | $3.9M | $2.9M | $1.0M | +37% |
Questions
How much did Intelligent Bio Solutions's revenue grow quarter over quarter in Q4 FY26?
Intelligent Bio Solutions's revenue rose $85K (+8%) from $1.1M in Q3 FY26 to $1.1M in Q4 FY26.
What drove Intelligent Bio Solutions's revenue change in Q4 FY26?
Sales of Goods - Readers +$90K (+65%); Sales of Goods - Cartidges −$79K (-11%); Other sales - accessories +$74K (+34%).